0001104659-20-064448.txt : 20200520
0001104659-20-064448.hdr.sgml : 20200520
20200520215915
ACCESSION NUMBER: 0001104659-20-064448
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200409
FILED AS OF DATE: 20200520
DATE AS OF CHANGE: 20200520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant V Luxco S.a r.l.
CENTRAL INDEX KEY: 0001786141
STATE OF INCORPORATION: N4
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 20899867
BUSINESS ADDRESS:
STREET 1: 15, BOULEVARD F.W. RAIFFEISEN
CITY: LUXEMBOURG
STATE: N4
ZIP: L-2411
BUSINESS PHONE: (415) 801-8100
MAIL ADDRESS:
STREET 1: 15, BOULEVARD F.W. RAIFFEISEN
CITY: LUXEMBOURG
STATE: N4
ZIP: L-2411
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Venture Capital V, L.P.
CENTRAL INDEX KEY: 0001589097
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 20899868
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Affiliates Fund V, L.P.
CENTRAL INDEX KEY: 0001589095
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 20899869
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ophthalmic Affiliates I, L.P.
CENTRAL INDEX KEY: 0001589098
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 20899870
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Venture Capital V (Canada), LP
CENTRAL INDEX KEY: 0001612235
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 20899871
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ventures V, LLC
CENTRAL INDEX KEY: 0001619298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 20899872
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-2215
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ventures V (Canada), L.P.
CENTRAL INDEX KEY: 0001716490
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 20899873
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: (650) 843-5000
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6095104718
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
a4.xml
4
X0306
4
2020-04-09
1
0001781983
Aprea Therapeutics, Inc.
APRE
0001786141
Versant V Luxco S.a r.l.
15 BOULEVARD F.W. RAIFFEISEN
2411 LUXEMBOURG
N4
L-2411
LUXEMBOURG
0
0
1
0
0001589097
Versant Venture Capital V, L.P.
15 BOULEVARD F.W. RAIFFEISEN
2411 LUXEMBOURG
N4
L-2411
LUXEMBOURG
0
0
1
0
0001589095
Versant Affiliates Fund V, L.P.
15 BOULEVARD F.W. RAIFFEISEN
2411 LUXEMBOURG
N4
L-2411
LUXEMBOURG
0
0
1
0
0001589098
Versant Ophthalmic Affiliates I, L.P.
15 BOULEVARD F.W. RAIFFEISEN
2411 LUXEMBOURG
N4
L-2411
LUXEMBOURG
0
0
1
0
0001612235
Versant Venture Capital V (Canada), LP
15 BOULEVARD F.W. RAIFFEISEN
2411 LUXEMBOURG
N4
L-2411
LUXEMBOURG
0
0
1
0
0001619298
Versant Ventures V, LLC
15 BOULEVARD F.W. RAIFFEISEN
2411 LUXEMBOURG
N4
L-2411
LUXEMBOURG
0
0
1
0
0001716490
Versant Ventures V (Canada), L.P.
15 BOULEVARD F.W. RAIFFEISEN
2411 LUXEMBOURG
N4
L-2411
LUXEMBOURG
0
0
1
0
Common Stock
2020-04-09
4
J
0
2519323
0
D
0
D
Common Stock
2020-04-09
4
J
0
2210937
0
A
2210937
D
Common Stock
2020-04-09
4
J
0
66506
0
A
66506
D
Common Stock
2020-04-09
4
J
0
73617
0
A
73617
D
Common Stock
2020-04-09
4
J
0
168263
0
A
168263
D
Common Stock
2020-05-18
4
J
0
773805
0
D
1437132
D
Common Stock
2020-05-18
4
J
0
23275
0
D
43231
D
Common Stock
2020-05-18
4
J
0
25794
0
D
47823
D
Common Stock
2020-05-18
4
J
0
58889
0
D
109374
D
Common Stock
2020-05-18
4
J
0
16428
0
A
16428
D
Common Stock
2020-05-18
4
J
0
16428
0
D
0
D
Common Stock
2020-05-18
4
J
0
1178
0
A
1178
D
Common Stock
2020-05-18
4
J
0
1178
0
D
0
D
Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant V Luxco S.a.r.l. ("Luxco") to its shareholders without consideration.
These Shares are directly held by Versant VI Luxco S.a.r.l. ("Luxco").
Luxco is majority owned by Versant Venture Capital V, L.P.("VVC V") and minority owned by Versant Ophthalmic Affiliates Fund I, L.P. ("VOA"), Versant Affiliates Fund V, L.P. ("VAF V" and together with VVC V and VOA, the "Versant Funds") and Versant Venture Capital V (Canada) LP ("VVC CAN"). Versant Ventures V, LLC ("VV V") is the general partner of each of the Versant Funds. Versant Ventures V GP-GP (Canada), Inc. ("VV V CAN GP") is the general partner of Versant Ventures V (Canada), L.P. ("VV V CAN"), which is the general partner of VVC CAN.
Represents a change in the form of ownership of VVC V by virtue of receipt of shares in the pro-rata in-kind distribution of Common Stock by Luxco.
These securities are held of record by VVC V. VV is the sole general partner of VVC V and may be deemed to have voting and investment power over the securities held by VVC V and as a result may be deemed to have beneficial ownership over such securities. VVC V disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.
Represents a change in the form of ownership of VAF V by virtue of receipt of shares in the pro-rata in-kind distribution of Common Stock by Luxco.
These securities are held of record by VAF V. VV V is the sole general partner of VAF V and may be deemed to have voting and investment power over the securities held by VAF V and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial owners of such shares except to the extent of its pecuniary interest therein.
Represents a change in the form of ownership of VOA by virtue of receipt of shares in the pro-rata in-kind distribution of Common Stock by Luxco.
These securities are held of record by VOA. VV V is the sole general partner of VOA and may be deemed to have voting and investment power over the securities held by VOA and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial ownership of such shares except to the extent of its pecuniary interests therein.
Represents a change in the form of ownership of VVC CAN by virtue of receipt of shares in the pro-rata in-kind distribution of Common Stock by Luxco.
These securities are held of record by VVC CAN. VV V CAN GP is the sole general partner of "VV V CAN and VV V CAN is the sole general partner of VVC CAN. By virtue of such relationships, VV V CAN GP and VV V CAN may be deemed to have voting and investment power over the securities held by VVC CAN and as a result may be deemed to have beneficial ownership over such securities. VV V CAN disclaims beneficial ownership of the shares held by VVC CAN, except to the extent of its pecuniary interests therein.
Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VVC V without consideration to its partners.
Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VAF V without consideration to its partners.
Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VOA without consideration to its partners.
Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VVC CAN without consideration to its partners.
Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by VVC V, VAF V and VOA.
The shares are held by VV V.
Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV V without consideration to its members.
Represents a change in the form of ownership of VV V CAN by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by VVC CAN.
The shares are held by VV V CAN.
Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV V CAN without consideration to its partners.
VERSANT V LUXCO S.A.R.L. By: /s/ Robin L. Praeger, Manager
2020-05-20
VERSANT VENTURE CAPITAL V, L.P. By: Versant Ventures V, LLC Its: General Partner By: /s/ Robin L. Praeger, Managing Director
2020-05-20
VERSANT AFFILIATES FUND V, L.P. By: Versant Ventures V, LLC Its: General Partner By: /s/ Robin L. Praeger, Managing Director
2020-05-20
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P. By: Versant Ventures V, LLC Its: General Partner By: /s/ Robin L. Praeger, Managing Director
2020-05-20
VERSANT VENTURE CAPITAL V (CANADA) LP By: Versant Ventures V (Canada), L.P. Its: General Partner By: Versant Ventures V GP-GP (Canada), Inc. Its: General Partner By: /s/ Robin L. Praeger, Director
2020-05-20
VERSANT VENTURES V, LLC By: /s/ Robin L. Praeger, Managing Director
2020-05-20
VERSANT VENTURES V (CANADA), L.P. By: Versant Ventures V GP-GP (Canada), Inc. Its: General Partner By: /s/ Robin L. Praeger, Director
2020-05-20